person

Patricia R.

Country
Portugal
Department
Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
51
Sites with multiple studies

Has run more than one trial at 51 of 176 partner sites.

Specializations

Hematologic Disorders

The investigator specializes in the study and treatment of systemic mastocytosis, with particular emphasis on the indolent form of this rare hematologic condition. Their research encompasses innovative therapeutic approaches for managing mast cell disorders.

  • Indolent Systemic Mastocytosis (ISM)
  • Smoldering Systemic Mastocytosis (SSM)
  • Mast Cell Proliferative Disorders

The investigator's work focuses on developing targeted therapies for patients with mast cell disorders, aiming to improve disease management and patient outcomes.

Targeted Therapeutics

This investigator concentrates on advancing targeted molecular therapies for hematologic conditions, specifically exploring novel treatment approaches for systemic mastocytosis variants.

  • Kinase Inhibitor Therapeutics
  • Novel Drug Development
  • Precision Medicine Approaches

Their research interests include investigating therapeutic agents that target specific molecular pathways involved in mast cell disorders.

Clinical Applications

The investigator's clinical focus encompasses the development of treatment protocols for patients with various forms of systemic mastocytosis, particularly addressing the needs of those with indolent disease presentations.

  • Disease Management Strategies
  • Symptom Control Approaches
  • Treatment Response Assessment

Their work involves evaluating therapeutic interventions that can effectively manage mast cell-related symptoms and improve quality of life.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.